CM Life Sciences II (CM Life Sciences II) Change In Receivables : $0.00 Mil (TTM As of Dec. 2020)

View and export this data going back to 2021. Start your Free Trial

What is CM Life Sciences II Change In Receivables?

CM Life Sciences II's change in receivables for the quarter that ended in Dec. 2020 was $0.00 Mil. It means CM Life Sciences II's Accounts Receivable stayed the same from . 20 to Dec. 2020 .

CM Life Sciences II's change in receivables for the fiscal year that ended in Dec. 2020 was $0.00 Mil. It means CM Life Sciences II's Accounts Receivable stayed the same from . 20 to Dec. 2020 .

CM Life Sciences II's Accounts Receivable for the quarter that ended in Dec. 2020 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CM Life Sciences II's liquidation value for the six months ended in Dec. 2020 was $-0.05 Mil.

CM Life Sciences II Change In Receivables Historical Data

The historical data trend for CM Life Sciences II's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CM Life Sciences II Change In Receivables Chart

CM Life Sciences II Annual Data

Trend

Dec20

Change In Receivables

CM Life Sciences II Semi-Annual Data
	Dec20
Change In Receivables	-

CM Life Sciences II Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2020 was $0.00 Mil.

CM Life Sciences II (NAS:CMIIU) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CM Life Sciences II's Days Sales Outstanding for the quarter that ended in Dec. 2020 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, CM Life Sciences II's accounts receivable are only considered to be worth 75% of book value:

CM Life Sciences II's liquidation value for the quarter that ended in Dec. 2020 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0	-	0.048	+	0.75 * 0	+	0.5 * 0
=	-0.05

CM Life Sciences II Change In Receivables Related Terms

Thank you for viewing the detailed overview of CM Life Sciences II's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.